Gynecological issues after organ transplantation

Area of Science:

• Transplantation Medicine
• Gynecology
• Immunology

Background:

• Organ transplantation is a standard treatment for end-stage organ failure.
• Immunosuppressive therapy is crucial for preventing graft rejection but increases infection risk.
• Immunosuppression can mask inflammatory symptoms and alter hormonal function.

Purpose of the Study:

• To review the gynecological considerations for women following organ transplantation.
• To highlight the impact of immunosuppression on reproductive health and cancer risk.
• To provide guidance on contraception, hormonal therapy, and screening in transplant recipients.

Main Methods:

• Literature review of studies on gynecological issues in organ transplant recipients.
• Analysis of data on infection rates, hormonal function, and fertility.
• Evaluation of safety and efficacy of contraception and hormone replacement therapy (HRT).

Main Results:

• Transplanted women often experience restored ovarian and menstrual function, but abnormal uterine bleeding is common.
• Endometrial hyperplasia is more frequent in renal graft recipients.
• Hormonal contraception and HRT show safety and acceptance; fertility is restored, necessitating contraception.
• Transplant patients have a significantly increased risk of malignancy, requiring regular gynecological screening.

Conclusions:

• Organ transplant recipients require specialized gynecological care, including appropriate contraception and HRT.
• Regular screening for gynecological and breast malignancies is essential for all transplant women.
• Management should address immunosuppression side effects, hormonal changes, and increased cancer risk.